Medicine Description iprivone 300 mg
iprivone 300 mg tablets is a medication designed to positively influence bone metabolism. It primarily acts by modulating the activity of osteoblasts and osteoclasts, the cells responsible for bone formation and resorption, respectively. Ipriflavone enhances bone density by inhibiting bone resorption, thereby reducing the rate of bone loss. Additionally, it may promote the deposition of calcium in the bone matrix and enhance the effects of vitamin D. This action helps to restore a balance in the bone remodeling process, making it particularly beneficial for individuals experiencing osteoporosis due to hormonal changes, such as post-menopausal women.
Indications and Uses of iprivone 300 mg tablets
- Treatment of osteoporosis in post-menopausal women
- Management of osteoporosis associated with aging
- Supportive therapy for patients with low bone density
- Adjunctive treatment in patients receiving glucocorticoid therapy
Side Effects of iprivone 300 mg tablets
- Nausea
- Dizziness
- Headache
- Gastrointestinal disturbances
- Skin rash
Storage and Handling
Store Iprivone 300 mg tablets in a cool, dry place away from light. Keep out of reach of children and do not use beyond the expiration date indicated on the package.
Patient Advice and Precautions
Consult a healthcare professional before starting treatment to ensure it is appropriate for your medical history. Monitor for potential side effects and report any unusual symptoms. It is essential to maintain a well-balanced diet rich in calcium and vitamin D while on treatment. Regular bone density assessments may be recommended to evaluate the effectiveness of therapy.